Projects
Projects funded in the main call
Funding period: 2015-2019
Total funding: € 10 million
Projects
Personalized combination therapies for high-grade serous ovarian cancer patients (OVCURE)
- Sampsa Hautaniemi, University of Helsinki
- Olli Carpen, University of Turku
- Seija Grenman, University of Turku
- Tero Aittokallio, University of Helsinki
Good(s) for health: Personalized health services and flexible appropriation of bioinformation (GoHe)
- Ilpo Helén, University of Eastern Finland
- Hanna Lehtimäki, University of Eastern Finland
- Karoliina Snell, University of Helsinki
Action on Human Surfaces: Wound-Metagenomics (Bugsy)
- Liisa Holm, University of Helsinki
- Esko Kankuri, University of Helsinki
- Jyrki Vuola, The Hospital District of Helsinki and Uusimaa
- Pekka Varmanen, University of Helsinki
- Matti Kankainen, University of Helsinki
Dietary Gluten-induced Disease Entities - from genomics to personalized Health and Well-being (DIG IN Health)
- Katri Kaukinen, Tampere University
- Seppo Meri, University of Helsinki
- Päivi Saavalainen, University of Helsinki
Finnish cardiomyopathies - from genetics and phenotype to pathogenesis (CardioPath)
- Johanna Kuusisto, University of Eastern Finland
- Markku Laakso, University of Eastern Finland
- Jari Koistinaho, University of Eastern Finland
- Pasi-Petri Tavi, University of Eastern Finland
Personalised medicine to predict and prevent Type 1 Diabetes (P4 Diabetes)
- Riitta Lahesmaa, University of Turku
- Matej Oresic, University of Turku
- Mikael Knip, University of Helsinki
- Raimo Lahti, University of Helsinki
- Jorma Toppari, University of Turku
- Harri Lähdesmäki, Aalto University
Dyslexia: genes, brain functions, interventions (DYSGEBRA)
- Heikki Lyytinen, University of Jyväskylä
- Riitta Salmelin, Aalto University
- Juha Kere, Folkhälsan Institute of Genetics
Effects of ApoE4 genotype information and intervention intensity on the fulfillment of lifestyle changes and sensory preferences (ApoE4mot)
- Susanna Rokka, Natural Resources Institute Finland (Luke)
- Anu Hopia, University of Turku
- Kirsi Vähäkangas, University of Eastern Finland
Neurogenomics in routine diagnostics of children and adults: impact on patient care and cost-effectiveness (NEUROGENOMICS FINLAND)
- Henna Tyynismaa, Univeristy of Helsinki
- Tuula Lönnqvist, The Hospital District of Helsinki and Uusimaa
- Mari Auranen, The Hospital District of Helsinki and Uusimaa
- Mika Kortelainen, VATT Institute for Economic Research
- Anu Wartiovaara, University of Helsinki
European Research Collaboration ERAPerMed, JTC2018 Call ”Research Projects on Personalized Medicine – Smart Combination of Pre-Clinical and Clinical Research with Data and ITC Solutions”
Funding period 1 Jan 2019 – 31 Dec 2021, total funding € 1 200 000
Projects
Novel individualized therapies in JAK/STAT driven T-cell malignancies (JAKSTAT-TARGET)
- Satu Mustjoki, University of Helsinki
- Tero Aittokallio, University of Helsinki
Genomics-based tools for personalized treatment to reduce chemotherapy burden in pediatric cancer (GEPARD)
- Olli Lohi, University of Turku
- Merja Heinäniemi, University of Eastern Finland
Clinical implementation Of Multidimensional PhenotypicAl drug SenSitivities in paediatric precision oncology (COMPASS)
- Olli Kallioniemi, University of Helsinki
Rational antiepileptic drug selection by combining gene network and ICT analysis
- Reetta Kälviäinen, University of Eastern Finland
European Research Collaboration ERAPerMed, JTC2019 Call ”Personalized Medicine: Multidisciplinary Research Towards Implementation”
Funding period 1 Jan 2020 – 31 Dec 2022, total funding € 1 199 751
Projects
Metabolic vulnerabilities for personalized therapeutic approaches in acute myeloid leukemia (MEET-AML)
- Caroline Heckman, University of Helsinki
A novel tool for personalized and socio-economically optimal treatment planning for patients with osteoarthritis
- Rami Korhonen, University of Eastern Finland
- Simo Saarakkala, University of Oulu
Temporal disease map based stratification of depression-related multimorbidities: towards quantitative investigations of patient trajectories and predictions of multi-target drug candidates
- Mikko Kuokkanen, National Institute for Health and Welfare
Advancing Breast Cancer histopathology towards AI-based Personalised medicine
- Pekka Ruusuvuori, Tampere University
- Leena Latonen, University of Eastern Finland
